iPath US Treasury 10-year Bear ETN
DTYS
Chicago Board Options Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Address
- IPO Date
- Aug 10, 2010
- Similar Companies
- Business
- iPath US Treasury 10-year Bear ETN (DTYS) is an exchange-traded note issued by Barclays Bank PLC that provides inverse exposure to the Barclays 10Y US Treasury Futures Targeted Exposure Index. The ETN seeks to deliver the inverse (-1x) daily performance of the index, which tracks 10-year US Treasury futures contracts to capture returns from rising yields or falling Treasury prices; it is structured as a senior, unsecured debt obligation of Barclays with an expense ratio of 0.75% and no dividend payments. Barclays issues DTYS as part of its broader iPath family of exchange-traded notes covering asset classes including commodities, volatility, and fixed income derivatives, targeting investors seeking bearish bets on US Treasury markets through a leveraged futures-based strategy. The ETN, launched on August 9, 2010, trades on US exchanges including NYSE Arca and is available to retail and institutional investors globally, with primary operations centered in the United States for the underlying Treasury futures market. Barclays Bank PLC, headquartered in London, UK, serves as the issuer and maintains global distribution through Barclays Capital Inc., with the product listed for trading in North American markets. In recent developments, Barclays announced suspensions and delistings for certain iPath ETNs, including a 2020 delisting notice for DTYS amid low liquidity, though it continued limited over-the-counter trading thereafter. Barclays has actively redeemed multiple iPath ETN series in 2025, including four series in June via issuer call options following tender offers and consent solicitations that amended indentures to enable full redemptions, with valuation dates set prior to redemption payments based on closing indicative values; while DTYS was not explicitly named in the June 2025 redemption list, ongoing tender activities and low trading volumes (e.g., recent prices around $4.48 with minimal activity) signal potential operational wind-down or further issuer actions consistent with Barclays' portfolio rationalization. No new product launches, acquisitions, or partnerships specific to DTYS were reported in the last 1-2 years, amid Barclays' broader strategy to manage iPath ETN maturities and liquidity risks.